Rengo Co., Ltd. (TYO:3941)

Verve Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	218,980	196,344	289,810	212,766	193,645	237,930
Market Cap Growth	-25.08%	-32.25%	36.21%	9.88%	-18.61%	14.13%
Enterprise Value	639,128	599,681	630,758	552,123	484,820	532,301
Last Close Price	883.40	792.30	1132.12	809.28	716.16	855.37
PE Ratio	10.43	6.78	8.78	10.42	6.87	8.32
Forward PE	8.13	6.38	8.00	6.61	6.14	8.47
PS Ratio	0.22	0.20	0.32	0.25	0.26	0.35
PB Ratio	0.44	0.39	0.66	0.55	0.55	0.73
P/TBV Ratio	0.53	0.47	0.77	0.66	0.63	0.86
P/FCF Ratio	-	-	11.30	61.58	16.58	9.00
P/OCF Ratio	-	2.55	3.23	4.62	3.35	3.61
PEG Ratio	1.87	2.39	0.52	1.21	0.67	5.49
EV/Sales Ratio	0.64	0.60	0.70	0.65	0.65	0.78
EV/EBITDA Ratio	5.78	6.18	6.24	7.51	6.28	6.65
EV/EBIT Ratio	17.29	16.03	12.91	21.27	14.57	13.33
EV/FCF Ratio	-	-	24.59	159.80	41.52	20.13
Debt / Equity Ratio	0.92	0.90	1.00	1.05	0.97	0.99
Debt / EBITDA Ratio	4.17	4.62	4.33	5.50	4.44	4.01
Debt / FCF Ratio	-	-	17.06	117.01	29.36	12.14
Asset Turnover	0.81	0.82	0.81	0.85	0.83	0.81
Inventory Turnover	7.85	8.55	8.42	9.18	10.36	10.76
Quick Ratio	0.86	0.85	0.99	0.85	0.88	0.85
Current Ratio	1.16	1.14	1.23	1.12	1.13	1.05
Return on Equity (ROE)	4.69%	6.51%	8.28%	5.78%	8.61%	9.53%
Return on Assets (ROA)	1.80%	1.94%	2.74%	1.63%	2.31%	2.95%
Return on Capital (ROIC)	2.38%	2.56%	3.66%	2.18%	3.10%	4.00%
Return on Capital Employed (ROCE)	4.30%	4.50%	6.30%	3.80%	5.30%	6.90%
Earnings Yield	9.58%	14.76%	11.39%	9.60%	14.56%	12.02%
FCF Yield	-	-9.73%	8.85%	1.62%	6.03%	11.12%
Dividend Yield	3.42%	3.79%	2.38%	2.97%	3.35%	2.81%
Payout Ratio	-	28.42%	18.10%	29.20%	21.16%	20.82%
Buyback Yield / Dilution	-0.04%	-0.04%	-0.01%	-0.02%	-0.02%	0.00%
Total Shareholder Return	3.38%	3.74%	2.38%	2.94%	3.33%	2.81%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.